Bioavailability Explained: Why Supplement Form Matters More Than the Dose on the Label (2026)
You buy a quercetin supplement. The label says 1,000 mg. You take it with water on an empty stomach. How much reaches your bloodstream? Between 1% and 5%. The rest is metabolized by your gut wall and liver before it ever enters circulation.
This is the central problem with longevity supplements: the milligrams on the label and the milligrams reaching your cells are almost never the same number. The gap between them is determined by bioavailability – and bioavailability is shaped by the form of the ingredient, the delivery system, and whether your supplement brand thought about any of this.
TL;DR – Key Takeaways
- Bioavailability = the fraction of a dose that reaches systemic circulation in its active form; measured by plasma AUC
- The first-pass effect: even if 70% is absorbed in the gut, the liver may convert 95%+ of it to inactive metabolites
- Quercefit (quercetin phytosome): 20x greater bioavailability than standard quercetin – 250 mg delivers more than 5,000 mg standard
- Encapsulated fisetin: 26.9x greater plasma AUC than standard fisetin
- Kaneka QH (ubiquinol): 3–8x greater plasma AUC than crystalline ubiquinone in older adults
- NMN benefits from the dedicated SLC12A8 intestinal transporter – good baseline bioavailability
- Lipophilic compounds (CoQ10, fisetin, quercetin, resveratrol) require dietary fat for absorption
What Bioavailability Means
Bioavailability is the fraction of an administered dose that reaches systemic circulation in its active form. For an intravenous drug, bioavailability is 100%. For an oral supplement, it is almost always less – often dramatically so.
Scientists measure it using AUC (area under the curve): blood samples at multiple timepoints after dosing, plotted as concentration over time. The area under that curve represents your body's total exposure to the active compound.
The first-pass effect is why oral bioavailability falls short. After swallowing a supplement, it travels to the small intestine, where some is degraded by enzymes and bacteria. What survives absorption enters the portal vein and goes directly to the liver, where it may be converted into inactive metabolites before reaching the bloodstream. Some compounds show 70% intestinal absorption but less than 5% systemic bioavailability because the liver aggressively metabolizes the parent molecule.
The Cases That Matter
Peter Attia and Andrew Huberman discuss why supplement form and bioavailability matter more than dose:
CoQ10 (coenzyme Q10 – an antioxidant that powers mitochondrial energy production): Ubiquinol vs. ubiquinone. Ubiquinol achieves 3–8x greater plasma AUC than crystalline ubiquinone in older adults (PMID 16919858). But formulation matters as much as form – two identical ubiquinone products can differ by 75% in bioavailability based on manufacturing process alone (PMC7278738). Look for stabilized ubiquinol, ideally nano-emulsified in MCT oil. Full story: CoQ10: The Mitochondrial Fuel.
Quercetin: Standard vs. phytosome. Quercefit (quercetin phytosome) delivers 20x the bioavailability of standard quercetin in a human crossover study (PMC6418071). This means 250 mg of Quercefit delivers more quercetin to your bloodstream than 5,000 mg of standard quercetin.
Fisetin: Standard vs. encapsulated. A 2022 human RCT (randomized controlled trial – the gold standard of clinical evidence) (PMC9574875) demonstrated that encapsulated fisetin achieved 26.9-fold greater plasma AUC than standard fisetin – the largest bioavailability enhancement in the senolytic ingredient space. Full story: Fisetin: The Most Potent Natural Senolytic.
NMN (nicotinamide mononucleotide – the direct precursor your body converts into NAD+): The transporter advantage. NMN benefits from the dedicated SLC12A8 transporter in the small intestine (Grozio et al., Nature Metabolism, 2019; PMC6530925), which directly transports intact NMN across the intestinal wall. The Yi et al. 2023 dose-finding study confirmed 600 mg/day produces approximately sixfold NAD+ (nicotinamide adenine dinucleotide – a coenzyme required for cellular energy and DNA repair) elevation, with no additional benefit at 900 mg.
Resveratrol: The bioavailability ceiling. Oral absorption is at least 70%, but systemic bioavailability is under 1% due to rapid sulfation and glucuronidation (PMID 15333514). Micronization improves dissolution and peak plasma concentrations, but first-pass metabolism remains the ceiling. Full story: Resveratrol in 2026.
Key Takeaway: The milligrams on your supplement label are not the milligrams reaching your cells. Quercefit delivers 20x more quercetin than standard forms, encapsulated fisetin achieves 26.9x greater plasma levels, and ubiquinol provides 3-8x more CoQ10 than ubiquinone. When evaluating any supplement, always ask: what form, and what is the actual bioavailability data?
The Fat Rule
Lipophilic compounds require dietary fat for absorption. The mechanism: bile acids released after a fat-containing meal form micelles in the small intestine that carry hydrophobic compounds across the intestinal wall.
A human study (PMID 23319447) found that a high-fat meal (15.4 g – about a tablespoon of olive oil) increased quercetin's Cmax by 45% and AUC by 32% vs. fat-free. You do not need a high-fat meal – any meal with some fat (eggs, avocado, nuts) engages the pathway.
Compounds that need fat: CoQ10, fisetin, quercetin, resveratrol. Compounds that do not: NMN, TMG (trimethylglycine – a methyl donor that supports the methylation cycle), taurine, PQQ (pyrroloquinoline quinone – a compound that stimulates new mitochondria growth).
Key Takeaway: Fat-soluble compounds like CoQ10, fisetin, quercetin, and resveratrol require dietary fat for absorption via bile acid micelles. Even a tablespoon of olive oil with your supplement dose makes a measurable difference. Water-soluble compounds like NMN and TMG do not need fat — take them whenever is most convenient.
Andrew Huberman's full episode on rational supplementation – covering bioavailability, form selection, and evidence-based dosing:
The "More Milligrams" Fallacy
Standard quercetin at 1,000 mg with ~2% bioavailability delivers approximately 20 mg to circulation. Quercefit at 250 mg with 20x bioavailability delivers the equivalent of 5,000 mg of standard quercetin. The 1,000 mg label number is marketing. The 250 mg Quercefit number is biology.
This is why branded ingredients matter. Uthever NMN has its own human RCT. Kaneka QH has decades of clinical data. BioPQQ is the only PQQ with human trial evidence. Quercefit has the 20x bioavailability data. Using generic versions of these ingredients and citing the branded ingredient's research is scientifically dishonest – and it is common in the supplement industry.
Key Takeaway: More milligrams does not mean more effect. A 250mg dose of Quercefit delivers more quercetin to your bloodstream than 5,000mg of standard quercetin. Always look for branded ingredients with their own bioavailability data — generic versions citing branded research is the supplement industry's most common sleight of hand.
Citations:
- PMC6418071 – Quercefit bioavailability study
- PMC9574875 – Fisetin encapsulated formulation RCT
- PMC6530925 – SLC12A8 NMN transporter
- PMID 15333514 – Resveratrol bioavailability
- PMID 16919858 – Kaneka QH bioavailability
- PMID 23319447 – Dietary fat quercetin absorption
Frequently Asked Questions
Q: What is bioavailability in supplements?
Bioavailability is the percentage of an ingested dose that reaches your systemic circulation in its active form. It is measured by tracking blood concentration over time (AUC). A supplement with 10% bioavailability means only 10% of the label dose reaches your bloodstream; the rest is either unabsorbed or converted to inactive metabolites before entering circulation.
Q: Why does supplement form matter so much?
The same compound in different forms can have dramatically different bioavailability. Quercetin phytosome (Quercefit) delivers 20x more quercetin to the bloodstream than standard quercetin. Encapsulated fisetin achieves 26.9x greater plasma AUC. Ubiquinol achieves 3–8x greater plasma levels than crystalline ubiquinone in older adults. Form determines how much of the dose label claim translates into actual cellular activity.
Q: Should I take fat-soluble supplements with food?
Yes – always take CoQ10, fisetin, quercetin, and resveratrol with a meal containing some dietary fat. These lipophilic compounds depend on bile acid micelles (stimulated by fat ingestion) to cross the intestinal wall. Even a small amount of fat (a tablespoon of olive oil, a few nuts) significantly increases absorption.
Q: What is the first-pass effect?
After intestinal absorption, nutrients travel via the portal vein directly to the liver before reaching systemic circulation. The liver may convert a large fraction of certain compounds into inactive metabolites in this first pass. Resveratrol is an extreme example: ~70% is absorbed from the gut, but less than 1% reaches the bloodstream as the active molecule due to aggressive hepatic conjugation.
Q: What does AUC mean in supplement research?
AUC (area under the curve) is the standard measurement of systemic exposure to a compound after dosing. It is calculated by measuring blood concentration at multiple timepoints and computing the total area under the resulting curve. A higher AUC means more of the compound reached the bloodstream and stayed there longer – which correlates with greater potential for biological activity.
Related Reading
- How to Read a Supplement Label
- Ubiquinol vs Ubiquinone: Which CoQ10 Form Actually Works?
- CoQ10 Ubiquinol: The Mitochondrial Fuel Your Body Stops Making After 40
- NMN vs NR: Which NAD+ Precursor Should You Take?
- Resveratrol in 2026: What 20 Years of Science Has Actually Proven
- Best Longevity Supplements 2026: The Evidence-Based Stack Guide
Daily Compounds – your habits are dialed. Your cells aren’t. Learn more →